Trials / Not Yet Recruiting
Not Yet RecruitingNCT06932393
Exosomes for Hairloss Treatment
A Randomized, Double-blind, Single-center, Self-controlled Exploratory Clinical Study of Exosomes for Hairloss Treatment
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human mesenchymal stem cells and purified using specific processing. This study is a randomized, double-blind, dose-escalation clinical trial designed to evaluate the efficacy and safety of exosomes therapy for alopecia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | exosomes | Each subject will receive 3 injections with an interval of one month. |
| OTHER | saline | Each subject will receive 3 injections with an interval of one month. |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2027-04-30
- Completion
- 2028-04-30
- First posted
- 2025-04-17
- Last updated
- 2025-04-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06932393. Inclusion in this directory is not an endorsement.